v3.26.3
SCHEDULE OF REVISION ON THE PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS (Details) - USD ($)
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2026
Jun. 30, 2026
Mar. 31, 2026
Sep. 30, 2025
Jun. 30, 2025
Mar. 31, 2025
Jun. 30, 2026
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Accounts receivable $ 13,249,849             $ 13,249,849   $ 2,485,882  
Total Current Assets 49,261,258             49,261,258   45,012,070  
Total Assets 66,285,031             66,285,031   63,591,924  
Accrued expenses 12,842,607             12,842,607   14,214,393  
Deferred revenue 10,433,507 $ 10,791,221   $ 11,959,891 $ 14,282,482   $ 10,791,221 10,433,507 $ 11,959,891 10,573,442 $ 16,824,629
Total Current Liabilities 61,704,732             61,704,732   39,579,411  
Total Liabilities 66,864,686             66,864,686   45,260,785  
Accumulated deficit 256,343,292             256,343,292   233,428,516  
Total LifeMD, Inc. Stockholders’ Equity 579,655             579,655   (18,331,139)  
Total Stockholders’ Equity 579,655 (2,982,176) $ (10,590,829) 852,331 8,376,918 $ 8,547,301 (2,982,176) 579,655 852,331 (18,331,139) 10,911,599
Total Liabilities and Stockholder’s Equity 66,285,031             66,285,031   63,591,924  
Cost of telehealth revenue 44,625,086     47,727,942       142,048,848 146,861,697    
Gross profit 36,375,617     40,666,291       122,442,971 125,233,796    
General and administrative expenses 14,654,524     13,800,377       43,468,661 42,995,255    
Total expenses 40,842,118     43,792,973       143,126,983 132,668,777    
Operating loss from continuing operations (4,466,501)     (3,126,682)       (20,684,012) (7,434,981)    
Loss from continuing operations before income taxes 4,469,713     4,543,154       20,585,088 9,975,878    
Net loss from continuing operations (4,469,713)     (4,574,977)       (20,585,088) (10,007,701)    
Net loss (4,469,713) (7,622,203) (8,493,172) (3,639,964) (2,174,550) 628,333   (20,585,088) (5,186,182)    
Net loss attributable to LifeMD, Inc. (4,469,713)     (3,889,426)       (20,585,088) (6,472,564)    
Net loss attributable to LifeMD, Inc. common stockholders $ (5,246,276)     $ (4,665,989)       $ (22,914,776) $ (8,802,252)    
Basic loss per share attributable to LifeMD, Inc. common stockholders $ (0.11)     $ (0.10)       $ (0.48) $ (0.20)    
Diluted loss per share attributable to LifeMD, Inc. common stockholders $ (0.11)     $ (0.10)       $ (0.48) $ (0.20)    
Accumulated deficit $ 579,655 (2,982,176) (10,590,829) $ 852,331 8,376,918 8,547,301 (2,982,176) $ 579,655 $ 852,331 (18,331,139) 10,911,599
Accounts receivable               (10,763,967) 2,618,396    
Deferred revenue               (139,935) (4,864,738)    
Accrued expenses               (1,371,786) (1,109,939)    
Net cash provided by operating activities of continuing operations               (7,430,657) 4,170,573    
Net cash used in operating activities               (7,430,657) 11,560,698    
Loss from continuing operations before income taxes (4,469,713)     (4,543,154)       (20,585,088) (9,975,878)    
Retained Earnings [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total Stockholders’ Equity 256,343,292 251,097,016 242,698,251 252,010,661 247,344,672 243,888,485 251,097,016 256,343,292 252,010,661 233,428,516 243,208,410
Net loss (4,469,713) (7,622,203) (8,493,172) (3,889,426) (2,679,625) 96,488          
Accumulated deficit $ 256,343,292 251,097,016 242,698,251 252,010,661 $ 247,344,672 $ 243,888,485 251,097,016 $ 256,343,292 252,010,661 233,428,516 243,208,410
Previously Reported [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Accounts receivable                   9,305,277  
Total Current Assets                   51,831,465  
Total Assets                   70,411,319  
Accrued expenses                   15,974,016  
Deferred revenue                   10,807,773  
Total Current Liabilities                   41,573,365  
Total Liabilities                   47,254,739  
Accumulated deficit                   228,603,075  
Total LifeMD, Inc. Stockholders’ Equity                   23,156,580  
Total Stockholders’ Equity                   23,156,580  
Total Liabilities and Stockholder’s Equity                   70,411,319  
Gross profit   41,996,762 44,237,457 52,764,557     86,234,219   163,492,506 166,340,390 133,383,276
General and administrative expenses   13,645,809 15,176,355 16,589,390     28,822,164   51,210,246 57,937,023 57,947,932
Total expenses   49,126,363 53,166,529 54,733,771     102,292,892   164,938,940 174,010,084 153,785,264
Operating loss from continuing operations   (7,129,601) (8,929,072) (1,969,214)     (16,058,673)   (1,446,434) (7,669,694) (20,401,988)
Loss from continuing operations before income taxes   7,083,941 8,872,596 3,387,521     15,956,537   4,154,043 (10,186,512) 22,577,393
Net loss from continuing operations   (7,083,941) (8,872,596) (3,556,655)     (15,956,537)   (4,323,177) (10,232,233) (23,175,393)
Net loss   (7,083,941) (8,872,596) (3,556,655)     (15,956,537)   (4,323,177) 15,619,791 (20,860,141)
Net loss attributable to LifeMD, Inc.   (7,083,941) (8,872,596) (3,806,117)     (15,956,537)   (5,609,559) 14,354,106 (21,409,016)
Net loss attributable to LifeMD, Inc. common stockholders   $ (7,860,503) $ (9,649,159) $ (4,582,680)     $ (17,509,662)   $ (7,939,247) $ 11,247,856 $ (24,515,266)
Basic loss per share attributable to LifeMD, Inc. common stockholders   $ (0.16) $ (0.20) $ (0.10)     $ (0.37)   $ (0.18) $ 0.25 $ (0.60)
Diluted loss per share attributable to LifeMD, Inc. common stockholders   $ (0.16) $ (0.20) $ (0.10)     $ (0.37)   $ (0.18) $ 0.25 $ (0.60)
Accumulated deficit                   $ 23,156,580  
Accounts receivable     $ (549,840)       $ (1,950,881)   $ 1,609,763 1,150,536 $ (4,487,546)
Deferred revenue     1,209,067       (16,552)   (5,270,408) (6,290,081) 9,826,219
Accrued expenses     (729,053)       987,170   (731,959) (5,782,603) 10,755,261
Net cash provided by operating activities of continuing operations                 11,560,698 2,072,304 14,363,313
Net cash used in operating activities     444,624       (6,481,023)   11,560,698 8,280,175 17,513,190
Loss from continuing operations before income taxes   $ (7,083,941) (8,872,596) $ (3,387,521)     (15,956,537)   (4,154,043) 10,186,512 (22,577,393)
Previously Reported [Member] | Retained Earnings [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total Stockholders’ Equity   246,112,737 238,252,234 247,790,178     246,112,737   247,790,178 228,603,075 239,850,931
Accumulated deficit   246,112,737 238,252,234 247,790,178     246,112,737   247,790,178 228,603,075 239,850,931
Previously Reported [Member] | Telehealth Revenue [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Cost of telehealth revenue   47,281,085 50,162,956 47,279,933     97,444,041   147,186,714 194,055,198 154,824,075
Previously Reported [Member] | Cost of Telehealth Revenue [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Cost of telehealth revenue     5,925,499 6,714,235     11,209,822   21,689,400 27,714,808 21,440,799
Revision of Prior Period, Reclassification, Adjustment [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Accounts receivable                   (6,819,395)  
Total Current Assets                   (6,819,395)  
Total Assets                   (6,819,395)  
Accrued expenses                   (1,759,623)  
Deferred revenue                   (234,331)  
Total Current Liabilities                   (1,993,954)  
Total Liabilities                   (1,993,954)  
Accumulated deficit                   4,825,441  
Total LifeMD, Inc. Stockholders’ Equity                   (4,825,441)  
Total Stockholders’ Equity                   (4,825,441)  
Total Liabilities and Stockholder’s Equity                   (6,819,395)  
Gross profit   (377,678) 210,813 100,593     (166,865)   (263,518) (714,200) (2,634,321)
General and administrative expenses   160,584 (168,611) 183,902     (8,027)   599,487 753,762 685,656
Total expenses   160,584 (168,611) 183,902     (8,027)   599,487 753,762 685,656
Operating loss from continuing operations   (538,262) 379,424 (83,309)     (158,838)   (863,005) (1,467,962) (3,319,977)
Loss from continuing operations before income taxes   538,262 (379,424) 83,309     158,838   863,005 (1,467,962) 3,319,977
Net loss from continuing operations   (538,262) 379,424 (83,309)     (158,838)   (863,005) (1,467,962) (3,319,977)
Net loss   (538,262) 379,424 (83,309)     (158,838)   (863,005) (1,467,962) (3,319,977)
Net loss attributable to LifeMD, Inc.   (538,262) 379,424 (83,309)     (158,838)   (863,005) (1,467,962) (3,319,977)
Net loss attributable to LifeMD, Inc. common stockholders   $ (538,262) $ 379,424 $ (83,309)     $ (158,838)   $ (863,005) $ (1,467,962) $ (3,319,977)
Basic loss per share attributable to LifeMD, Inc. common stockholders   $ (0.02)       $ (0.02) $ (0.03) $ (0.08)
Diluted loss per share attributable to LifeMD, Inc. common stockholders   $ (0.02)       $ (0.02) $ (0.03) $ (0.08)
Accumulated deficit                   $ (4,825,441)  
Accounts receivable     $ 90,112       $ 694,776   $ 1,103,965 2,348,242 $ 4,471,153
Deferred revenue     234,331       234,331   85,117 38,894 (273,225)
Accrued expenses     (703,867)       (770,269)   (326,077) (919,174) (877,951)
Net cash provided by operating activities of continuing operations                
Net cash used in operating activities            
Loss from continuing operations before income taxes   $ (538,262) 379,424 $ (83,309)     (158,838)   (863,005) 1,467,962 (3,319,977)
Revision of Prior Period, Reclassification, Adjustment [Member] | Retained Earnings [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total Stockholders’ Equity   4,984,279 4,446,017 4,220,483     4,984,279   4,220,483 4,825,441 3,357,479
Accumulated deficit   4,984,279 4,446,017 4,220,483     4,984,279   4,220,483 4,825,441 3,357,479
Revision of Prior Period, Reclassification, Adjustment [Member] | Telehealth Revenue [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Cost of telehealth revenue   (377,678) 357,399 448,009     (20,279)   (325,017) (237,006) (1,979,194)
Revision of Prior Period, Reclassification, Adjustment [Member] | Cost of Telehealth Revenue [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Cost of telehealth revenue     146,586 347,416     146,586   (61,499) 477,194 655,127
As Revised [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Accounts receivable                   2,485,882  
Total Current Assets                   45,012,070  
Total Assets                   63,591,924  
Accrued expenses                   14,214,393  
Deferred revenue                   10,573,442  
Total Current Liabilities                   39,579,411  
Total Liabilities                   45,260,785  
Accumulated deficit                   233,428,516  
Total LifeMD, Inc. Stockholders’ Equity                   18,331,139  
Total Stockholders’ Equity                   18,331,139  
Total Liabilities and Stockholder’s Equity                   63,591,924  
Gross profit   41,619,084 44,448,270 52,865,150     86,067,354   163,228,988 165,626,190 130,748,955
General and administrative expenses   13,806,393 15,007,744 16,773,292     28,814,137   51,809,733 58,690,785 58,633,588
Total expenses   49,286,947 52,997,918 54,917,673     102,284,865   165,538,427 174,763,846 154,470,920
Operating loss from continuing operations   (7,667,863) (8,549,648) (2,052,523)     (16,217,511)   (2,309,439) (9,137,656) (23,721,965)
Loss from continuing operations before income taxes   7,622,203 8,493,172 3,470,830     16,115,375   5,017,048 (11,654,474) 25,897,370
Net loss from continuing operations   (7,622,203) (8,493,172) (3,639,964)     (16,115,375)   (5,186,182) (11,700,195) (26,495,370)
Net loss   (7,622,203) (8,493,172) (3,639,964)     (16,115,375)   (5,186,182) 14,151,829 (24,180,118)
Net loss attributable to LifeMD, Inc.   (7,622,203) (8,493,172) (3,889,426)     (16,115,375)   (6,472,564) 12,886,144 (24,728,993)
Net loss attributable to LifeMD, Inc. common stockholders   $ (8,398,765) $ (9,269,735) $ (4,665,989)     $ (17,668,500)   $ (8,802,252) $ 9,779,894 $ (27,835,243)
Basic loss per share attributable to LifeMD, Inc. common stockholders   $ (0.18) $ (0.20) $ (0.10)     $ (0.37)   $ (0.20) $ 0.22 $ (0.68)
Diluted loss per share attributable to LifeMD, Inc. common stockholders   $ (0.18) $ (0.20) $ (0.10)     $ (0.37)   $ (0.20) $ 0.22 $ (0.68)
Accumulated deficit                   $ 18,331,139  
Accounts receivable     $ (459,728)       $ (1,256,105)   $ 2,713,728 3,498,778 $ (16,393)
Deferred revenue     1,443,398       217,779   (5,185,291) (6,251,187) 9,552,994
Accrued expenses     (1,432,920)       216,901   (1,058,036) (6,701,777) 9,877,310
Net cash provided by operating activities of continuing operations                 11,560,698 2,072,304 14,363,313
Net cash used in operating activities     444,624       (6,481,023)   11,560,698 8,280,175 17,513,190
Loss from continuing operations before income taxes   $ (7,622,203) (8,493,172) $ (3,470,830)     (16,115,375)   (5,017,048) 11,654,474 (25,897,370)
As Revised [Member] | Retained Earnings [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total Stockholders’ Equity   251,097,016 242,698,251 252,010,661     251,097,016   252,010,661 233,428,516 243,208,410
Accumulated deficit   251,097,016 242,698,251 252,010,661     251,097,016   252,010,661 233,428,516 243,208,410
As Revised [Member] | Telehealth Revenue [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Cost of telehealth revenue   $ 46,903,407 50,520,355 47,727,942     97,423,762   146,861,697 193,818,192 152,844,881
As Revised [Member] | Cost of Telehealth Revenue [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Cost of telehealth revenue     $ 6,072,085 7,061,651     $ 11,356,408   21,627,901 $ 28,192,002 $ 22,095,926
Discontinued Operations [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Gross profit       12,198,859         37,995,192    
General and administrative expenses       2,972,915         8,814,478    
Total expenses       11,124,700         32,869,650    
Operating loss from continuing operations       1,074,159         5,125,542    
Loss from continuing operations before income taxes       (1,072,324)         (4,958,830)    
Net loss from continuing operations       935,013         4,821,519    
Net loss                  
Net loss attributable to LifeMD, Inc.                  
Net loss attributable to LifeMD, Inc. common stockholders                  
Basic loss per share attributable to LifeMD, Inc. common stockholders                  
Diluted loss per share attributable to LifeMD, Inc. common stockholders                  
Accounts receivable                 $ 95,332    
Deferred revenue                 (320,553)    
Accrued expenses                 51,903    
Net cash provided by operating activities of continuing operations                 7,390,125    
Net cash used in operating activities                    
Loss from continuing operations before income taxes       $ 1,072,324         4,958,830    
Discontinued Operations [Member] | Retained Earnings [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total Stockholders’ Equity                  
Accumulated deficit                  
Discontinued Operations [Member] | Telehealth Revenue [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Cost of telehealth revenue                  
Discontinued Operations [Member] | Cost of Telehealth Revenue [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Cost of telehealth revenue                  
As Revised And Recast [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Gross profit       40,666,291         125,233,796    
General and administrative expenses       13,800,377         42,995,255    
Total expenses       43,792,973         132,668,777    
Operating loss from continuing operations       (3,126,682)         (7,434,981)    
Loss from continuing operations before income taxes       4,543,154         9,975,878    
Net loss from continuing operations       (4,574,977)         (10,007,701)    
Net loss       (3,639,964)         (5,186,182)    
Net loss attributable to LifeMD, Inc.       (3,889,426)         (6,472,564)    
Net loss attributable to LifeMD, Inc. common stockholders       $ (4,665,989)         $ (8,802,252)    
Basic loss per share attributable to LifeMD, Inc. common stockholders       $ (0.10)         $ (0.20)    
Diluted loss per share attributable to LifeMD, Inc. common stockholders       $ (0.10)         $ (0.20)    
Accounts receivable                 $ 2,618,396    
Deferred revenue                 (4,864,738)    
Accrued expenses                 (1,109,939)    
Net cash provided by operating activities of continuing operations                 4,170,573    
Net cash used in operating activities                 11,560,698    
Loss from continuing operations before income taxes       $ (4,543,154)         (9,975,878)    
As Revised And Recast [Member] | Retained Earnings [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Total Stockholders’ Equity       252,010,661         252,010,661    
Accumulated deficit       252,010,661         252,010,661    
As Revised And Recast [Member] | Telehealth Revenue [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Cost of telehealth revenue       47,727,942         146,861,697    
As Revised And Recast [Member] | Cost of Telehealth Revenue [Member]                      
New Accounting Pronouncements or Change in Accounting Principle [Line Items]                      
Cost of telehealth revenue       $ 7,061,651         $ 21,627,901